1. Home
  2. PPBT vs HTOO Comparison

PPBT vs HTOO Comparison

Compare PPBT & HTOO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PPBT
  • HTOO
  • Stock Information
  • Founded
  • PPBT 2010
  • HTOO 2020
  • Country
  • PPBT Israel
  • HTOO Ireland
  • Employees
  • PPBT N/A
  • HTOO N/A
  • Industry
  • PPBT Biotechnology: Pharmaceutical Preparations
  • HTOO Natural Gas Distribution
  • Sector
  • PPBT Health Care
  • HTOO Utilities
  • Exchange
  • PPBT Nasdaq
  • HTOO Nasdaq
  • Market Cap
  • PPBT 6.3M
  • HTOO 6.1M
  • IPO Year
  • PPBT N/A
  • HTOO N/A
  • Fundamental
  • Price
  • PPBT $2.40
  • HTOO $0.20
  • Analyst Decision
  • PPBT Strong Buy
  • HTOO
  • Analyst Count
  • PPBT 1
  • HTOO 0
  • Target Price
  • PPBT $33.00
  • HTOO N/A
  • AVG Volume (30 Days)
  • PPBT 23.8K
  • HTOO 755.5K
  • Earning Date
  • PPBT 08-15-2025
  • HTOO 12-04-2023
  • Dividend Yield
  • PPBT N/A
  • HTOO N/A
  • EPS Growth
  • PPBT N/A
  • HTOO N/A
  • EPS
  • PPBT N/A
  • HTOO N/A
  • Revenue
  • PPBT N/A
  • HTOO $1,661,663.00
  • Revenue This Year
  • PPBT N/A
  • HTOO $4,832.46
  • Revenue Next Year
  • PPBT N/A
  • HTOO $81.82
  • P/E Ratio
  • PPBT N/A
  • HTOO N/A
  • Revenue Growth
  • PPBT N/A
  • HTOO N/A
  • 52 Week Low
  • PPBT $2.00
  • HTOO $0.19
  • 52 Week High
  • PPBT $13.95
  • HTOO $1.02
  • Technical
  • Relative Strength Index (RSI)
  • PPBT 47.68
  • HTOO 28.58
  • Support Level
  • PPBT $2.26
  • HTOO $0.19
  • Resistance Level
  • PPBT $2.45
  • HTOO $0.23
  • Average True Range (ATR)
  • PPBT 0.14
  • HTOO 0.03
  • MACD
  • PPBT -0.01
  • HTOO -0.01
  • Stochastic Oscillator
  • PPBT 44.12
  • HTOO 9.45

About PPBT Purple Biotech Ltd.

Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219: A dual inhibitor, small molecule that simultaneously targets Insulin Receptor Substrate 1 and 2 (IRS1/2) and Signal Transducer and Activator of Transcription (STAT3), two survival signal transduction pathways driving the development of cancer drug resistance. and CM24: is a humanized monoclonal antibody designed to block the interactions of Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 (CEACAM1), a glycoprotein that plays a key role in immune regulation, cell adhesion, and tumor progression, CAPTN3.

About HTOO Fusion Fuel Green PLC

Fusion Fuel Green PLC is a company that has developed a Green Hydrogen production technology. It is focused on generating cost-effective and competitively priced Green Hydrogen.

Share on Social Networks: